Unknown

Dataset Information

0

Optimized expression and specific activity of IL-12 by directed molecular evolution.


ABSTRACT: DNA delivery of IL-12 has shown promise in reducing the toxic side effects associated with administration of recombinant human (h)IL-12 protein while maintaining the ability to inhibit tumor growth and abolish tumor metastases in animal models. We have developed a more potent version of IL-12 by using DNA shuffling and screening to improve its expression in human cells and specific activity on human T cells. The most improved evolved IL-12 (EvIL-12) derived from seven mammalian genes encoding both the p35 and p40 subunits of IL-12 showed a 128-fold improvement in human T cell proliferation compared with native hIL-12 during the initial screening of supernatants from transected cells. When purified hIL-12 and EvIL-12 proteins were compared in vitro in human T cell proliferation and Th1 differentiation assays, it was demonstrated that EvIL-12 exhibited a concomitant 10-fold increase in the specific activity of the protein compared with hIL-12. Furthermore, DNA shuffling improved the level of expression and homogeneity of the heterodimer synthesized by 293 human embryonic kidney cells transfected with EvIL-12 by at least 10-fold. Molecular analysis of the variant revealed strategic placement of amino acid substitutions that potentially may facilitate heterodimer formation and product expression. The enhanced expression and biological activity of EvIL-12 may improve the effectiveness of IL-12 gene-based vaccines and therapeutics without the toxic side effects sometimes associated with hIL-12 protein administration.

SUBMITTER: Leong SR 

PROVIDER: S-EPMC298744 | biostudies-literature | 2003 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Optimized expression and specific activity of IL-12 by directed molecular evolution.

Leong Steven R SR   Chang Jean C C JC   Ong Randal R   Dawes Glenn G   Stemmer Willem P C WP   Punnonen Juha J  

Proceedings of the National Academy of Sciences of the United States of America 20030115 3


DNA delivery of IL-12 has shown promise in reducing the toxic side effects associated with administration of recombinant human (h)IL-12 protein while maintaining the ability to inhibit tumor growth and abolish tumor metastases in animal models. We have developed a more potent version of IL-12 by using DNA shuffling and screening to improve its expression in human cells and specific activity on human T cells. The most improved evolved IL-12 (EvIL-12) derived from seven mammalian genes encoding bo  ...[more]

Similar Datasets

| S-EPMC4086129 | biostudies-literature
| S-EPMC4221479 | biostudies-literature
| S-EPMC6350686 | biostudies-literature
| S-EPMC14682 | biostudies-literature
| S-EPMC3489740 | biostudies-literature
| S-EPMC2366932 | biostudies-literature
| S-EPMC4786629 | biostudies-literature
| S-EPMC4718545 | biostudies-literature
| S-EPMC6728054 | biostudies-literature
| S-EPMC6208966 | biostudies-literature